为你的基因组测序

2015-09-09 佚名 生物谷

世界领先基因测序公司Illumina的首席执行官(CEO)声称,他晓得了如何让消费者对基因测序感兴趣:创建一个庞大的APP应用商店来储存基因信息。 据报道,Illumina近日与美国华平投资集团和苏特—希尔投资公司合作为一个叫做“Helix”(意为“螺旋”)的公司注资1亿美元,这家公司的目的是让基因测序进入互联网的主流。 开一家基因测序APP商店 很多科技公司都对基因组的价值怦然心动,I

世界领先基因测序公司Illumina的首席执行官(CEO)声称,他晓得了如何让消费者对基因测序感兴趣:创建一个庞大的APP应用商店来储存基因信息。

据报道,Illumina近日与美国华平投资集团和苏特—希尔投资公司合作为一个叫做“Helix”(意为“螺旋”)的公司注资1亿美元,这家公司的目的是让基因测序进入互联网的主流。

开一家基因测序APP商店

很多科技公司都对基因组的价值怦然心动,Illumina尤其如此。

这家公司坐落在美国圣迭戈,在目前的竞争中属于获胜者。它已经控制了美国基因测序市场的大部分。去年其基因测序装置、药物和实验为其带来18亿美元的收入。

在美国,基因测序工作主要由医院里的实验室来做,也有几个国家性的项目在做。Helix的成立与最后一块未被碰触的市场有关:普通消费者。

但是直到现在,消费者对基因测序的兴趣不温不火。想想看,你身边有谁的基因组已经被测序过?原因在于,对于健康的人而言,基因测序似乎并没有那么重要。即使基因组测序的成本已经大为降低——只有2000美元左右,但对大多数人而言,这是不值得的。

一个专门用于基因测序的应用商店,至少让它看起来不那么“高冷”。

Illumina的CEO杰伊·弗拉特里在接受采访时表示,等明年Helix上线时,它将会为消费者的基因组测序并储存相关信息,然后再将这些信息卖给平台里的APP。

Helix的目的是激发能够反复利用基因信息的应用软件的开发。第一批入驻这一平台的合作伙伴包括美国医学实验室公司LabCorp和梅约诊所。如果Helix取得成功,它将是世界上最大的基因测序实验室。

对基因测序定制化收费

既然消费者认为基因测序“不值得”,如何吸引他们参与进来?Helix的对策是:定制化收费。

弗拉特里说,市场调研显示消费者只愿意为获得某种基因信息——如家谱分析——付出99美元。这种定制收费模式可以有效解决全基因测序费用过高的问题。

比如说你从Helix平台里下载一款APP,想弄明白你是否具有某种特定的基因变异,例如好多运动员都拥有的“速度基因”。你需要给Helix寄送一份唾液样本,它将会将分析结果通过APP发送给你,这可能会花费你几十美元。

不过弗拉特里表示,除了那些没有明确医学相关性的基因,Helix也可以对你进行全基因测序,这总共会花费500美元左右。由于Helix已经存储了你的基因信息,如果你想用平台上另一个APP对其进行其他分析,可以马上将这些基因信息调出来使用。

“我们正押注消费者们会回来使用更多服务,然后你不用进行第二次测序。”弗拉特里说。

弗拉特里表示,Helix将储存基因信息并将其提供给所有平台上的APP。就像苹果的应用商店从销售出的每份“愤怒的小鸟”游戏中获得提成一样,基因测序的利润将在Helix和入驻商之间分配。

他并没有提分成比例如何,但是说到了一个重要的调整:用户的基因信息每次被其他APP使用时,首次劝说用户寄送唾液样本的入驻商都会获利一次。

期待“杀手级”APP出现

Helix背后的点子非常酷——你的基因信息存储在云端,并可以被时髦的APP访问。另外,源源不断的基因信息对Helix而言绝对是个宝藏,因为基因信 息的好处将越来越多地被科学家发现。弗拉特里说:“随着科学技术越来越强大,基因信息也将越来越有价值,而消费者将为基因信息买单。”

但是它也有弊端,最重要的就是隐私问题。弗拉特里表示,Helix的信息存储将会非常安全。但是别忘了,Helix的目标就是让你心甘情愿地将自己的基因信息提供给商业性APP,就像交出你的手机通讯录和你的位置信息一样。

不过这并不妨碍大趋势的发展。现在很多科技企业都期待基因测序与消费者碰撞出火花,谷歌和苹果都在进行类似的探索。

在此之前,Illumina曾“突袭”过APP领域,但是并没有获得成功。它发布了一个叫做“基础空间”的APP供研究者使用,并没有“红”起来。所以要 实现成功,Helix可能需要一个“杀手级”的APP,让人们忍不住在公交车和电梯中不断地查看、使用。

弗拉特里表示,Helix的目标之一就是“激发那些大的开发者团体,让更多的人关注这一领域并发现杀手级的应用”。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=57290, encodeId=c7705e29015, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57291, encodeId=c5a75e2910c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57292, encodeId=fd665e2920c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57293, encodeId=83695e293c9, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57294, encodeId=bfc85e294d1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57295, encodeId=4fa05e29515, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438150, encodeId=c29f1438150f0, content=<a href='/topic/show?id=48f9418406e' target=_blank style='color:#2F92EE;'>#基因组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41840, encryptionId=48f9418406e, topicName=基因组测序)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 11 00:13:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36623, encodeId=a9933662313, content=期待进一步的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e73d1605484, createdName=he408015781, createdTime=Thu Sep 10 10:17:00 CST 2015, time=2015-09-10, status=1, ipAttribution=)]
    2016-01-14 medsic

    嗯,

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=57290, encodeId=c7705e29015, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57291, encodeId=c5a75e2910c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57292, encodeId=fd665e2920c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57293, encodeId=83695e293c9, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57294, encodeId=bfc85e294d1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57295, encodeId=4fa05e29515, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438150, encodeId=c29f1438150f0, content=<a href='/topic/show?id=48f9418406e' target=_blank style='color:#2F92EE;'>#基因组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41840, encryptionId=48f9418406e, topicName=基因组测序)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 11 00:13:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36623, encodeId=a9933662313, content=期待进一步的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e73d1605484, createdName=he408015781, createdTime=Thu Sep 10 10:17:00 CST 2015, time=2015-09-10, status=1, ipAttribution=)]
    2016-01-14 medsic

    嗯,

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=57290, encodeId=c7705e29015, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57291, encodeId=c5a75e2910c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57292, encodeId=fd665e2920c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57293, encodeId=83695e293c9, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57294, encodeId=bfc85e294d1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57295, encodeId=4fa05e29515, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438150, encodeId=c29f1438150f0, content=<a href='/topic/show?id=48f9418406e' target=_blank style='color:#2F92EE;'>#基因组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41840, encryptionId=48f9418406e, topicName=基因组测序)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 11 00:13:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36623, encodeId=a9933662313, content=期待进一步的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e73d1605484, createdName=he408015781, createdTime=Thu Sep 10 10:17:00 CST 2015, time=2015-09-10, status=1, ipAttribution=)]
    2016-01-14 medsic

    good

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=57290, encodeId=c7705e29015, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57291, encodeId=c5a75e2910c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57292, encodeId=fd665e2920c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57293, encodeId=83695e293c9, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57294, encodeId=bfc85e294d1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57295, encodeId=4fa05e29515, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438150, encodeId=c29f1438150f0, content=<a href='/topic/show?id=48f9418406e' target=_blank style='color:#2F92EE;'>#基因组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41840, encryptionId=48f9418406e, topicName=基因组测序)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 11 00:13:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36623, encodeId=a9933662313, content=期待进一步的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e73d1605484, createdName=he408015781, createdTime=Thu Sep 10 10:17:00 CST 2015, time=2015-09-10, status=1, ipAttribution=)]
    2016-01-14 medsic

    good

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=57290, encodeId=c7705e29015, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57291, encodeId=c5a75e2910c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57292, encodeId=fd665e2920c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57293, encodeId=83695e293c9, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57294, encodeId=bfc85e294d1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57295, encodeId=4fa05e29515, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438150, encodeId=c29f1438150f0, content=<a href='/topic/show?id=48f9418406e' target=_blank style='color:#2F92EE;'>#基因组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41840, encryptionId=48f9418406e, topicName=基因组测序)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 11 00:13:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36623, encodeId=a9933662313, content=期待进一步的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e73d1605484, createdName=he408015781, createdTime=Thu Sep 10 10:17:00 CST 2015, time=2015-09-10, status=1, ipAttribution=)]
    2016-01-14 medsic

    感谢分享

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=57290, encodeId=c7705e29015, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57291, encodeId=c5a75e2910c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57292, encodeId=fd665e2920c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57293, encodeId=83695e293c9, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57294, encodeId=bfc85e294d1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57295, encodeId=4fa05e29515, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438150, encodeId=c29f1438150f0, content=<a href='/topic/show?id=48f9418406e' target=_blank style='color:#2F92EE;'>#基因组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41840, encryptionId=48f9418406e, topicName=基因组测序)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 11 00:13:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36623, encodeId=a9933662313, content=期待进一步的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e73d1605484, createdName=he408015781, createdTime=Thu Sep 10 10:17:00 CST 2015, time=2015-09-10, status=1, ipAttribution=)]
    2016-01-14 medsic

    感谢分享

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=57290, encodeId=c7705e29015, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57291, encodeId=c5a75e2910c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57292, encodeId=fd665e2920c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57293, encodeId=83695e293c9, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57294, encodeId=bfc85e294d1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57295, encodeId=4fa05e29515, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438150, encodeId=c29f1438150f0, content=<a href='/topic/show?id=48f9418406e' target=_blank style='color:#2F92EE;'>#基因组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41840, encryptionId=48f9418406e, topicName=基因组测序)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 11 00:13:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36623, encodeId=a9933662313, content=期待进一步的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e73d1605484, createdName=he408015781, createdTime=Thu Sep 10 10:17:00 CST 2015, time=2015-09-10, status=1, ipAttribution=)]
  8. [GetPortalCommentsPageByObjectIdResponse(id=57290, encodeId=c7705e29015, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57291, encodeId=c5a75e2910c, content=嗯,, beContent=null, objectType=article, channel=null, level=null, likeNumber=107, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57292, encodeId=fd665e2920c, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=129, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57293, encodeId=83695e293c9, content=good, beContent=null, objectType=article, channel=null, level=null, likeNumber=106, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57294, encodeId=bfc85e294d1, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=123, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=57295, encodeId=4fa05e29515, content=感谢分享, beContent=null, objectType=article, channel=null, level=null, likeNumber=76, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32ba1611217, createdName=medsic, createdTime=Thu Jan 14 13:05:00 CST 2016, time=2016-01-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1438150, encodeId=c29f1438150f0, content=<a href='/topic/show?id=48f9418406e' target=_blank style='color:#2F92EE;'>#基因组测序#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=21, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=41840, encryptionId=48f9418406e, topicName=基因组测序)], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/aLGWoFXAyMbIu3qymFOyheQLjPSX3OUs5GmkyBlcCOwTPIeq3why9NGibxxUqYo6hcx8qZLHZFgNPnBK1yzWeOFpyg2OnWOt0/0, createdBy=fa4716, createdName=zhouqu_8, createdTime=Fri Sep 11 00:13:00 CST 2015, time=2015-09-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=36623, encodeId=a9933662313, content=期待进一步的研究, beContent=null, objectType=article, channel=null, level=null, likeNumber=79, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=e73d1605484, createdName=he408015781, createdTime=Thu Sep 10 10:17:00 CST 2015, time=2015-09-10, status=1, ipAttribution=)]
    2015-09-10 he408015781

    期待进一步的研究

    0

相关资讯

Mol Diagn Ther:34个癌症相关的基因测序对黑色素瘤患者的利好消息

背景:通过对比单点BRAF V600突变的测试,确定新一代34个癌症相关基因测序(NGS)面板对转移性黑色素瘤患者是否是经济效益的治疗选择。 方法:开发了一项决策模型来评估两个测试策略的成本和健康结果。两个测试策略的成本效益从付款人的角度进行分析,两年的时间范围模型参数取自文献。 结果:在基本情况下,基因测序面板的策略花费成本120022美元,每个病人0.721质量调整生存期,而单点突变测试策

精准药物开发面临哪些真实的困境?

《自然》(Nature)杂志英文版日前发表文章称,要想把靶向疗法用于更多患者,需要将基因组数据与临床数据相整合,让这些信息能够被广泛接入。 10个月前,来自新泽西的一位76岁尿道癌晚期患者的医生们决定为她尝试一种非传统疗法。几周前,他们把这位患者的肿瘤样本发给威尔康奈尔医学院(Weill Cornell Medical College)精准药物(Precision Medicine)研究所。

欧美权威机构发布NIPT的10条建议

近日,欧洲人类遗传学学会和美国人类遗传学学会发表联合声明,对临床实践中的无创产前筛查(NIPT)提出了10条建议。这些建议发表在《European Journal of Human Genetics》杂志上,从伦理的角度讨论了NIPT的未来。自从首个基因测序的无创产前检测在2011年推出以来,这些检测被迅速采用,以筛查21、18和13三体,以及性染色体非整倍体和微缺失综合征。“NIPT有望更好地实

Nature Methods:针对LncRNAs的新型精准基因测序技术

现在有一种新的基因测序技术-“捕获测序'(CaptureSeq),能使我们以更高的分辨率去探索人类基因组。它优于现有的基因测序技术,能精确捕捉测量许多具体的活性基因样品(即使基因的表达时间仅按分钟水平计算)。这个技术对癌症研究具有革命性的影响。在实际应用中,可用于包括许血液肿瘤的诊断。这篇文章由澳大利亚悉尼加文研究所的研究人员发表在昨天的Nature Methods。 人类有大约20,000个基

55家互联网基因检测公司的测评质量报告

WeGene这家深圳企业成立不到一年就推出了基因测序服务,200+项检测结果,价格是1299元。高大上的基因测序服务真的走入寻常百姓家?还是你也像我一样,对互联网基因测序睁大了惊讶和疑惑的眼睛? 随着个体化医疗和临床癌症基因组研究的发展,不断有研究结果表明,癌症基因组或其他个体化医疗诊断能达到很好的临床效果。利用网络营销策略可以提高人们对个体化医疗和基因检测的认识,以及扩大基因检测服务的销售面

想知道你的遗传命运吗?

你想知道你和你的孩子是否有遗传癌症的风险吗?你想知道你和你的孩子们是否存在患心血管疾病的风险,是否携带阿尔茨海默病的相关基因吗?即使这些疾病可能在几十年内都与你不相关或者至今没有治疗方法。 只需取少量血液或唾液,通过全基因组测序的方法就能使你获得你想知道的那些问题的答案,在一项研究中,有超过一半的父母表示,他们不仅对这项技术在自身上的应用感兴趣,也期望对他们的孩子应用全基因组测序